Ignite Creation Date:
2024-05-06 @ 7:08 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05904886
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-05-23
Brief Title:
A Study Evaluating Atezolizumab and Bevacizumab With or Without Tiragolumab in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma IMbrave152
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Organization Data
Organization:
Hoffmann-La Roche
Class:
INDUSTRY
Study ID:
CO44668
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hoffmann-La Roche
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Chugai Pharmaceutical | INDUSTRY |